Magnesium flux compendium: Discover ligands, channels, and metabolic signals
Magnesium flux compendium: Discover ligands, channels, and metabolic signals
批准号:
10627888
负责人:
MADESH MUNISWAMY
金额:
$49.9万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-06-01 至 2027-05-31
关键词:
Acinar CellBindingBiochemical ReactionBioenergeticsBiologicalBiophysicsBuffersCRISPR/Cas technologyCationsCell membraneCell modelCell physiologyCellsCellular biologyComplexCytosolDeficiency DiseasesDissociationEndosomesEnzymesEquilibriumEventFunctional disorderFundingFutureHomeostasisHormonalIon ChannelLaboratoriesLigandsLinkLysosomesMagnesiumMembraneMetabolicMetabolismMgATPMitochondriaMitochondrial MatrixMolecularNucleic AcidsNucleotidesOrganellesPhenotypePhysiologicalProteinsRNA interference screenRestRoleRouteShapesSignal PathwaySignal TransductionStimulusTestingWorkcofactorionizationmouse modelprogramsuptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT/SUMMARY
Free ionized intracellular Mg2+ (iMg2+) is estimated to be in the range of 0.5–1.2 mM. In general, it is accepted
that under resting conditions, the concentration of ionized cytosolic Mg2+ is `muffled' by phosphometabolites,
nucleic acids and proteins. For example, ATP binds with a Kd value of 50 M-70 μM and therefore Mg2+ in the
cytosol and the mitochondrial matrix is primarily complexed with ATP (Mg-ATP2-). Because of its abundance (~5
mM), ATP is considered to be the largest iMg2+ `store'. Fluctuations in free cytosolic (cMg2+) following hormonal
stimuli have been touted as passive adjustments of Mg2+ dissociating from the exuberant Mg-ATP contingent
and other `buffered' pools of Mg2+. Apart from iMg2+ `buffering' mechanism, Mg2+ ion channels and transporters
controlling Mg2+ entry as well as efflux across the plasma membrane are thought to maintain the equilibrium of
free cMg2+. Currently, several candidates are correlated to Mg2+ entry machinery (TRPM6, TRPM7, MagT1), but
are still awaiting convincing biophysical and physiological evidence for such roles. The Mg2+/Na+ exchanger
SLC41A1 was proposed to contribute Mg2+ efflux from the cell, whereas Mrs2 was proposed as a mitochondrial
Mg2+ transporter. Very little is known about the molecular details of Mg2+ transport into/from cellular organelles
like the ER, mitochondria, endosomes and lysosomes. A few studies have speculated that free [Mg2+] in the ER
and mitochondria are likely to be similar to [cMg2+]. However, the temporal and spatial dynamics, let alone the
biological relevance of iMg2+ mobilization, remain a mystery in cell biology. Nevertheless, Mg2+ is an essential
cation controlling many biochemical reactions. Our recent work has shown that L-lactate acts as an activator that
triggers a dynamic transfer of Mg2+ between the ER and mitochondria to shape bioenergetics and cellular
metabolism (Cell 2020). Mechanistically, L-lactate stimulates Mg2+ release from the ER followed by Mg2+ uptake
by mitochondria. The mitochondrial localized Mrs2 transporter was found to be responsible for the accumulation
of Mg2+ in mitochondria. However, the L-lactate-induced ER release molecular machinery remains unidentified.
I propose to identify ER Mg2+ release component, plasma membrane entry machinery and the resultant
molecular signaling pathways. I will take advantage of unbiased RNAi screen and targeted CRISPR/Cas9 editing
approaches to answer these mysteries in the Mg2+ signaling field. Identification of these molecular machineries
would aid in our understanding of iMg2+ dynamics and the cause-effect relationships that exist between iMg2+ flux
and cellular processes. Additionally, I will test and define the Mg2+-dependent signaling events based on the
cellular and mouse model phenotypes. It is thrilling to define the molecular link between cellular Mg2+
homeostasis and physiological function. Our identification and characterization of the Mg2+ flux components will
further investigate how, and if, these signaling routes impinge on the pathophysiology of a growing number of
Mg2+ deficiency diseases in humankind. Overall, the R35/MIRA funding will support the testing of this
unconventional hypothesis and my laboratory will address these major mysteries in the near future.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Magnesium flux compendium: Discover ligands, channels, and metabolic signals
-
批准号:10662656
-
项目类别:
-
资助金额:$22.43万
-
财政年份:2022
-
负责人:MADESH MUNISWAMY
-
依托单位:
Magnesium flux compendium: Discover ligands, channels, and metabolic signals
-
批准号:10791996
-
项目类别:
-
资助金额:$25.0万
-
财政年份:2022
-
负责人:MADESH MUNISWAMY
-
依托单位:
Magnesium flux compendium: Discover ligands, channels, and metabolic signals
-
批准号:10405276
-
项目类别:
-
资助金额:$21.14万
-
财政年份:2022
-
负责人:MADESH MUNISWAMY
-
依托单位:
Essential Role for SPG7 in Mitochondrial Permeability Transition Pore Assembly and Function
-
批准号:10241316
-
项目类别:
-
资助金额:$30.72万
-
财政年份:2020
-
负责人:MADESH MUNISWAMY
-
依托单位:
Inhibition of MCUR1-MCU mediated mitochondrial Ca2+ uptake prevents I/R injury
-
批准号:8694610
-
项目类别:
-
资助金额:$38.94万
-
财政年份:2014
-
负责人:MADESH MUNISWAMY
-
依托单位:
Molecular mechanism of Ca2+-induced mitochondrial shape transition in metazoans
-
批准号:10062506
-
项目类别:
-
资助金额:$46.11万
-
财政年份:2014
-
负责人:MADESH MUNISWAMY
-
依托单位:
Molecular mechanism of Ca2+-induced mitochondrial shape transition in metazoans
-
批准号:10527556
-
项目类别:
-
资助金额:$2.46万
-
财政年份:2014
-
负责人:MADESH MUNISWAMY
-
依托单位:
Inhibition of MCUR1-MCU mediated mitochondrial Ca2+ uptake prevents I/R injury
-
批准号:8824559
-
项目类别:
-
资助金额:$38.42万
-
财政年份:2014
-
负责人:MADESH MUNISWAMY
-
依托单位:
Inhibition of MCUR1-MCU mediated mitochondrial Ca2+ uptake prevents I/R injury
-
批准号:9032520
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2014
-
负责人:MADESH MUNISWAMY
-
依托单位:
Molecular mechanism of Ca2+-induced mitochondrial shape transition in metazoans
-
批准号:10331786
-
项目类别:
-
资助金额:$39.97万
-
财政年份:2014
-
负责人:MADESH MUNISWAMY
-
依托单位:
ROS-dependent STIM1 activation and Ca2+ entry in lung inflammation
-
批准号:8303299
-
项目类别:
-
资助金额:$19.13万
-
财政年份:2011
-
负责人:MADESH MUNISWAMY
-
依托单位:
ROS-dependent STIM1 activation and Ca2+ entry in lung inflammation
-
批准号:8176178
-
项目类别:
-
资助金额:$22.95万
-
财政年份:2011
-
负责人:MADESH MUNISWAMY
-
依托单位:
Multiphoton Confocal Microscopy for Biomedical Research
-
批准号:7795484
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2010
-
负责人:MADESH MUNISWAMY
-
依托单位:
Coordination of Pathophysiologic Endothelial Cell Signaling by ROS
-
批准号:7839727
-
项目类别:
-
资助金额:$27.22万
-
财政年份:2009
-
负责人:MADESH MUNISWAMY
-
依托单位:
Coordination of Pathophysiologic Endothelial Cell Signaling by ROS
-
批准号:7523782
-
项目类别:
-
资助金额:$32.25万
-
财政年份:2008
-
负责人:MADESH MUNISWAMY
-
依托单位:
Coordination of Pathophysiologic Endothelial Cell Signaling by ROS
-
批准号:7908894
-
项目类别:
-
资助金额:$33.75万
-
财政年份:2008
-
负责人:MADESH MUNISWAMY
-
依托单位:
Coordination of Pathophysiologic endothelial cell signaling by ROS
-
批准号:9015464
-
项目类别:
-
资助金额:$46.86万
-
财政年份:2008
-
负责人:MADESH MUNISWAMY
-
依托单位:
Coordination of Pathophysiologic endothelial cell signaling by ROS
-
批准号:8632382
-
项目类别:
-
资助金额:$48.54万
-
财政年份:2008
-
负责人:MADESH MUNISWAMY
-
依托单位:
Coordination of Pathophysiologic endothelial cell signaling by ROS
-
批准号:8820275
-
项目类别:
-
资助金额:$47.05万
-
财政年份:2008
-
负责人:MADESH MUNISWAMY
-
依托单位:
Coordination of Pathophysiologic Endothelial Cell Signaling by ROS
-
批准号:7675423
-
项目类别:
-
资助金额:$33.75万
-
财政年份:2008
-
负责人:MADESH MUNISWAMY
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: